Patrick W. Smith - Feb 7, 2025 Form 4 Insider Report for Oncocyte Corp (OCX)

Role
10%+ Owner
Signature
/s/ Patrick W. Smith
Stock symbol
OCX
Transactions as of
Feb 7, 2025
Transactions value $
$2,999,999
Form type
4
Date filed
2/11/2025, 05:00 PM
Previous filing
Feb 4, 2025
Next filing
Mar 26, 2025
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction OCX Common Stock, no par value Purchase $2.21M +1.08M +60.03% $2.05 2.87M Feb 7, 2025 See footnote F1, F2
transaction OCX Common Stock, no par value Other $791K +386K +13.43% $2.05 3.26M Feb 7, 2025 See footnote F2, F3
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Reflects shares of the Issuer's common stock, no par value, purchased by the Reporting Person from the Issuer in a private placement pursuant to that certain Securities Purchase Agreement, dated as of February 7, 2025, by and among the Issuer and the investors signatory thereto.
F2 The shares of common stock reported herein are directly held by PATRICK W SMITH TTEE THE SMITH IRREVOCABLE TRUST U/A DTD 05/01/2015 (the "Trust"). As the trustee of the Trust, the Reporting Person may be deemed to beneficially own the securities held by the Trust.
F3 Reflects shares of the Issuer's common stock, no par value, purchased by the Reporting Person from the Issuer in a registered direct offering pursuant to that certain Securities Purchase Agreement, dated as of February 7, 2025, by and among the Issuer and the investors signatory thereto.